Daniela Mennickent

Ms. Daniela Mennickent

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2022 in Artificial Intelligence in Medicine
Verified
Journal Article
Closed access
DMDaniela Mennickent
Daniela Mennickent
ARAndrés Rodríguez
Andrés Rodríguez
MFMarcelo Farías-Jofré
Marcelo Farías-Jofré
JAJuan Araya
Juan Araya
EGEnrique Guzmán-Gutiérrez
Enrique Guzmán-Gutiérrez

4 April 2022 in Frontiers in Physiology
Verified
Journal Article
Open access
BOB. Ortega-Contreras
B. Ortega-Contreras
AAA. Armella
A. Armella
JAJ. Appel
J. Appel
DMDaniela Mennickent
Daniela Mennickent
JAJ. Araya
J. Araya
EGEnrique Guzmán-Gutiérrez
Enrique Guzmán-Gutiérrez
Gestational Diabetes Mellitus (GDM) is a highly prevalent maternal pathology characterized by maternal glucose intolerance during pregnancy that is, associated with severe complications for both mother and offspring. Several risk factors have been related to GDM; one of the most important among them is genetic predisposition. Numerous single nucleotide polymorphisms (SNPs) in genes that act at different levels on various tissues, could cause changes in the expression levels and activity of proteins, which result in glucose and insulin metabolism dysfunction. In this review, we describe various SNPs; which according to literature, increase the risk of developing GDM. These SNPs include: (1) those associated with transcription factors that regulate insulin production and excretion, such as rs7903146 (TCF7L2) and rs5015480 (HHEX); (2) others that cause a decrease in protective hormones against insulin resistance such as rs2241766 (ADIPOQ) and rs6257 (SHBG); (3) SNPs that cause modifications in membrane proteins, generating dysfunction in insulin signaling or cell transport in the case of rs5443 (GNB3) and rs2237892 (KCNQ1); (4) those associated with enzymes such as rs225014 (DIO2) and rs9939609 (FTO) which cause an impaired metabolism, resulting in an insulin resistance state; and (5) other polymorphisms, those are associated with growth factors such as rs2146323 (VEGFA) and rs755622 (MIF) which could cause changes in the expression levels of these proteins, producing endothelial dysfunction and an increase of pro-inflammatory cytokines, characteristic on GDM. While the pathophysiological mechanism is unclear, this review describes various potential effects of these polymorphisms on the predisposition to develop GDM.

24 November 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SGSebastián Gutiérrez-Vega
Sebastián Gutiérrez-Vega
AAAxel Armella
Axel Armella
DMDaniela Mennickent
Daniela Mennickent
MLMarco Loyola
Marco Loyola
ACAmbart Covarrubias
Ambart Covarrubias
EGEnrique Guzmán-Gutiérrez
Enrique Guzmán-Gutiérrez
Gestational Diabetes Mellitus (GDM) is characterized by abnormal maternal D-glucose metabolism and altered insulin signaling. Dysregulation of thyroid hormones (TH) tri-iodethyronine (T3) and L-thyroxine (T4) Hormones had been associated with GDM, but the physiopathological meaning of these alterations is still unclear. Maternal TH cross the placenta through TH Transporters and their Deiodinases metabolize them to regulate fetal TH levels. Currently, the metabolism of TH in placentas with GDM is unknown, and there are no other studies that evaluate the fetal TH from pregnancies with GDM. Therefore, we evaluated the levels of maternal TH during pregnancy, and fetal TH at delivery, and the expression and activity of placental deiodinases from GDM pregnancies. Pregnant women were followed through pregnancy until delivery. We collected blood samples during 10–14, 24–28, and 36–40 weeks of gestation for measure Thyroid-stimulating hormone (TSH), Free T4 (FT4), Total T4 (TT4), and Total T3 (TT3) concentrations from Normal Glucose Tolerance (NGT) and GDM mothers. Moreover, we measure fetal TSH, FT4, TT4, and TT3 in total blood cord at the delivery. Also, we measured the placental expression of Deiodinases by RT-PCR, western-blotting, and immunohistochemistry. The activity of Deiodinases was estimated quantified rT3 and T3 using T4 as a substrate. Mothers with GDM showed higher levels of TT3 during all pregnancy, and an increased in TSH during second and third trimester, while lower concentrations of neonatal TT4, FT4, and TT3; and an increased TSH level in umbilical cord blood from GDM. Placentae from GDM mothers have a higher expression and activity of Deiodinase 3, but lower Deiodinase 2, than NGT mothers. In conclusion, GDM favors high levels of TT3 during all gestation in the mother, low levels in TT4, FT4 and TT3 at the delivery in neonates, and increases deiodinase 3, but reduce deiodinase 2 expression and activity in the placenta.

1 January 2021 in Placenta
Verified
Journal Article
Closed access
JAJuan Araya
Juan Araya
ARAndrés Rodriguez
Andrés Rodriguez
KLKarin Lagos-SanMartin
Karin Lagos-SanMartin
DMDaniela Mennickent
Daniela Mennickent
SGSebastián Gutiérrez-Vega
Sebastián Gutiérrez-Vega
EGEnrique Guzmán-Gutiérrez
Enrique Guzmán-Gutiérrez

8 January 2019 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
JGJaviera Gavilan
Javiera Gavilan
DMDaniela Mennickent
Daniela Mennickent
OROscar Ramírez
Oscar Ramírez
STSergio Triviño
Sergio Triviño
CPClaudia Perez
Claudia Perez
JFJorge Fuentealba
Jorge Fuentealba
Alzheimer’s disease (AD) is a neurodegenerative pathology, which is characterized by progressive and irreversible cognitive impairment. Most of the neuronal perturbations described in AD can be associated with soluble amyloid– β oligomers (SO-Aβ ). T

21 May 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
DMDaniela Mennickent
Daniela Mennickent
LRLucas Romero-Albornoz
Lucas Romero-Albornoz
SGSebastián Gutiérrez-Vega
Sebastián Gutiérrez-Vega
Claudio AguayoClaudio Aguayo
Claudio Aguayo
Federico MariniFederico Marini
Federico Marini
JAJuan Araya
Juan Araya
Gestational diabetes mellitus (GDM) is a hyperglycemic state that is typically diagnosed by an oral glucose tolerance test (OGTT), which is unpleasant, time-consuming, has low reproducibility, and results are tardy. The machine learning (ML) predictive models that have been proposed to improve GDM diagnosis are usually based on instrumental methods that take hours to produce a result. Near-infrared (NIR) spectroscopy is a simple, fast, and low-cost analytical technique that has never been assessed for the prediction of GDM. This study aims to develop ML predictive models for GDM based on NIR spectroscopy, and to evaluate their potential as early detection or alternative screening tools according to their predictive power and duration of analysis. Serum samples from the first trimester (before GDM diagnosis) and the second trimester (at the time of GDM diagnosis) of pregnancy were analyzed by NIR spectroscopy. Four spectral ranges were considered, and 80 mathematical pretreatments were tested for each. NIR data-based models were built with single- and multi-block ML techniques. Every model was subjected to double cross-validation. The best models for first and second trimester achieved areas under the receiver operating characteristic curve of 0.5768 ± 0.0635 and 0.8836 ± 0.0259, respectively. This is the first study reporting NIR-spectroscopy-based methods for the prediction of GDM. The developed methods allow for prediction of GDM from 10 µL of serum in only 32 min. They are simple, fast, and have a great potential for application in clinical practice, especially as alternative screening tools to the OGTT for GDM diagnosis.